Geographical Group Reporting Submission

Group Cochrane Balearic Islands

Name Ignacio Ricci-Cabello

Activity name / title Evidence production

Which function does this relate to?

Tier one N/A

Tier two N/A

Tier three N/A

Tier four N/A

Evidence production Other review and evidence production

If other, please explain In April 2025, the methodological article “Comparison between two tools assessing the methodological quality of systematic reviews: ReMarQ and AMSTAR 2” was published in Clinical and Public Health Guidelines. Pau Riera Serra, member of the Cochrane Iberoamérica – Balearic Islands node, contributed as a co-author. The study compared the performance and agreement between the ReMarQ and AMSTAR 2 tools across 51 systematic reviews. Results showed a strong correlation between the tools, supporting the use of ReMarQ for large-scale or automated assessments.

Date

Start date 01-04-2025

Proposed end date 01-04-2025

on-going No

Was this activity in collaboration with other organization(s) or partner(s)? If so which? No

Person to contact if any queries about this activity Ignacio Ricci Cabello
ignacio.ricci@idisba.es

Type of activity Evidence production

Please give additional activity details (i.e., reach, impact, duration, return on investment) In April 2025, the methodological article “Comparison between two tools assessing the methodological quality of systematic reviews: ReMarQ and AMSTAR 2” was published in Clinical and Public Health Guidelines. Pau Riera Serra, member of the Cochrane Iberoamérica – Balearic Islands node, contributed as a co-author. The study compared the performance and agreement between the ReMarQ and AMSTAR 2 tools across 51 systematic reviews. Results showed a strong correlation between the tools, supporting the use of ReMarQ for large-scale or automated assessments.

Link and documents

Documents

clinical-and-public-health-guidelines---2025.pdf

By checking this box, my center consents to the use of these photos for Cochrane internal and external purposes, such as websites, reports, social media, etc. Yes